Delivery Order SPE2DB22D2206-SPE2DB24FKM92

Award Date 9/27/24
Potential Completion Date 9/30/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKM92
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and equipment to support various government healthcare programs, including military treatment facilities and veterans' hospitals. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure essential medical commodities from AmerisourceBergen. The contract does not have a set-aside designation.

Generated 12/27/24, 9:18 AM